Skip to Content
Couple sitting at a kitchen table reviewing information on a notepad.
Article

Life insurance: Update on cancer, diabetes, COVID-19, and marijuana use

August 5, 2021 / 5 min read

Years ago, certain diseases or marijuana use would have been instant impediments to reasonably priced life insurance. Today’s medical advancements, current actuarial mortality expectations, and evolving social norms have changed that. Here’s what you need to know.

The COVID-19 pandemic has led many people to recognize the importance of life insurance in helping protect loved ones and business partners in the event of an untimely death. However, some erroneously believe they’re unable to obtain a reasonably priced life insurance policy due to a challenging medical history or certain lifestyle choices.

Years ago, applicants with a history of cancer, diabetes, or marijuana use would have been unable to obtain life insurance at reasonable prices. But today, with medical advancements, new medications, and current actuarial mortality expectations, things have changed.

It’s important to recognize that life insurance pricing isn’t based solely on health. Factors such as driving record, criminal history, and avocation history are additional components. However, health has been — and likely will continue to be — the primary focus.

A history of cancer causes many to automatically believe they can’t obtain life insurance or, if they can, only at very high prices. Fortunately, that isn’t always true. Those diagnosed with lower-stage cancer and have been in remission will generally have a better chance to qualify for life insurance at a very good health rating and attractive pricing. This is especially true if they were diagnosed with a non-invasive form of cancer (Stage 0) and have remained cancer-free for several years.

A history of cancer causes many to automatically believe they can’t obtain life insurance or, if they can, only at very high prices.

As for those who may be in remission after being diagnosed with a more invasive form of cancer, it’s still possible to qualify for life insurance but health ratings will more likely be impacted. You’ll probably need to pay a little bit more, but it can still be affordable. Just remember: typically, the longer you’ve been cancer-free,  the easier it is to get attractively priced life insurance.

Diabetes is another ailment that causes many to feel life insurance is an impossibility. The reality is some life insurance companies specialize in people with diabetes. One such company actively markets to diabetics and has a solution designed for those living with it. If you have diabetes, it doesn’t mean you can’t protect your family or your business by having to live without well-priced life insurance.

What about COVID-19? The impact of COVID-19 varies from one insurance company to the next, with some being more lenient than others. If you’ve been diagnosed with COVID-19, insurance companies generally will postpone your case for at least 30 days – perhaps longer if additional time is needed for a full recovery. If you were diagnosed with COVID-19 and were hospitalized and/or hospitalized and ventilated, insurance companies may postpone your case for 180 days or longer before they’ll consider it.

The impact of COVID-19 varies from one insurance company to the next, with some being more lenient than others. 

Marijuana is increasingly becoming legal in many states for recreational use. Interestingly, marijuana use doesn’t necessarily result in “smoker” pricing (which is extremely high and often unaffordable). Most who use marijuana will usually fall into one of three groups: 

Life insurance companies will commonly assess marijuana use based on:

For recreational users of marijuana, common insurance company underwriting results are:

While securing life insurance may have been impossible in the past due to certain types of diseases and lifestyle choices, that’s not the case any longer. For help working through and assessing your medical history for life insurance purposes, give us a call.

Securities are offered through Valmark Securities Inc. member FINRA and SIPC, an unaffiliated securities brokerdealer.

The material contained in the herein is for informational purpose only and is not intended to provide specific advice or recommendations for any individual, nor does it take into account the particular investment objectives, financial situation or needs of individual investors. Consult your financial professional before making any investment decision. The information provided has been derived from sources believed to be reliable, but is not guaranteed as to accuracy. Valmark Securities supervises all life settlements like a security transaction and its’ registered representatives act as brokers on the transaction and may receive a fee from the purchaser. Once a policy is transferred, the policy owner has no control over subsequent transfers and may be required to disclosure additional information later. If a continued need for coverage exists, the policy owner should consider the availability, adequacy and cost of the comparable coverage. A life settlement transaction may require an extended period to complete and result in higher costs and fees due to their complexity. Policy owners considering the need for cash should consider other less costly alternatives. A life settlement may affect the insured’s ability to obtain insurance in the future and the seller’s eligibility for certain public assistance programs. When an individual decides to sell their policy, they must provide complete access to their medical history, and other personal information.

Related Thinking

Couple on their laptop computer planning for their year end finances.
November 20, 2024

7 tax planning items to consider before year-end

Article 5 min read
Couple assessing their estate plan.
November 18, 2024

It’s time to revisit your estate plan: A comprehensive guide

Article 5 min read
Spouses discussing a SLAT with their financial advisor.
November 1, 2024

Use it or lose it: Consider a SLAT before the estate tax sunset

Article 5 min read